|
|
|
Corporate Profile: XTL
Biopharmaceuticals
| Summary: |
| XTL
Biopharmaceuticals is engaged in the research, development,
and commercialization of therapeutics for the treatment
of hepatitis C and multiple myeloma. |
| Address (HQ): |
711 Executive Blvd.
Suite Q
Valley Cottage, NY 10989 |
| Phone #'s (HQ): |
| Main |
(845) 267-0707 x225 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
(845) 267-0926 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| email: |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
IR@xtlbio.com |
| Financial
information: |
| XTLBY |
| Internet
job postings: |
| not
known |
| Number
of employees: |
| not
known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
